Check-Points

  • Check-Direct CPE

    Active Screening for Carbapenemases
    by Real-Time PCR

    KPC - OXA-48 - VIM - NDM Rapid Molecular Detection of Carbapenemase-Producing Enterobacteriaceae Kits for 48 reactions now available

    Download brochure (PDF) ›

  • Check-MDR Real-Time PCR

    Real-Time detection of carbapenemases
    and ESBLs

    Detect carbapenemases or ESBL with high sensitivity and specificity Objective results in 4.5 hours & use in your Real-Time labflow Kits for 24 reactions now available

    More info ›

  • Check-MDR CT platform

    Microarray identification of carbapenemase, ESBL and AmpC genes

    Confirm suspected multidrug resistance Improve your epidemiological insight Exclude outbreaks

    More info ›
Our products

Check-Points offers a range of rapid molecular assays Our products support you in identifying and controlling the spread of carbapenemases, ESBLs and AmpCs & rapid molecular serotyping of Salmonella.

antibiotic resistance

Antibiotic Resistance

The presence of multidrug resistance (MDR) in Gram-negative bacteria makes infections caused by these bacteria extremely difficult to treat. Such bacteria, which produce carbapenemases, ESBLs and AmpCs, are now increasing sharply and spreading worldwide.

Real-Time PCR

Check-Points Reader

Detect the clinically most prevalent carbapenemases or ESBLs in just 4.5 hours. By utilizing existing Real-Time equipment and a standard thermal profile, the Check-MDR Real-Time PCR assays can easily be used in your Real-Time labflow.

Microarray

Check&Trace kit

Pinpoint the presence of multidrug resistance genes through simultaneous analysis of up to 100 specific DNA markers. The Check-MDR CT products are the first to detect carbapenemases, ESBLs and AmpCs in a single test.

23rd ECCMID

More info 27-30 April

Connect with us at the 23rd ECCMID in Berlin.

Booth number 511

 

ECCMID logo

Recent News

Testimonials

"It provided definitive results within the same working day, allowing rapid implementation of isolation measures and appropriate antibiotic treatment" Naas et al. Antimicrobial Agents